Onderneming Pathfinder Cell Therapy, Inc. Other OTC
Aandelen
PFND
US70319A1060
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per regio
USD in miljoen | 2012 | Gewicht | 2013 | Gewicht | Delta |
---|---|---|---|---|---|
Russia
50,0
%
| 0 | 13,2 % | 0 | 50,0 % | +80,00% |
Czech Republic
18,5
%
| 0 | 13,2 % | 0 | 18,5 % | -33,33% |
Brazil
14,8
%
| 0 | 14,9 % | 0 | 14,8 % | -52,94% |
Hong Kong
11,1
%
| 0 | 32,5 % | 0 | 11,1 % | -83,78% |
Other Countries
5,6
%
| - | - | 0 | 5,6 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 02-09-11 |
John Benson
DFI | Director of Finance/CFO | 62 | 02-09-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 02-09-11 |
John Benson
DFI | Director of Finance/CFO | 62 | 02-09-11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 667 160 870 | 667 160 870 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Pathfinder Cell Therapy, Inc.
12 Bow Street
02138-5104, Cambridge
+
http://www.pathfindercelltherapy.com![Adres Pathfinder Cell Therapy, Inc.(PFND)](https://cdn.zonebourse.com/static/address/9016897.png)
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,14% | 51,12 mld. | |
-6,54% | 39,4 mld. | |
+34,92% | 38,48 mld. | |
-12,11% | 26,22 mld. | |
+12,62% | 26,36 mld. | |
-13,43% | 20,96 mld. | |
+43,73% | 14,02 mld. | |
+31,81% | 12,49 mld. | |
-4,54% | 11,61 mld. |